Trial Profile
An Open-Label Study to Evaluate the Single-Dose Pharmacokinetics, Safety, and Tolerability of Doripenem in Infants (Term and Preterm), Less Than 12 Weeks Chronological Age.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Jul 2019
Price :
$35
*
At a glance
- Drugs Doripenem (Primary)
- Indications Gram-negative infections; Gram-positive infections; Intra-abdominal infections; Nosocomial pneumonia; Respiratory tract infections; Urinary tract infections
- Focus Pharmacokinetics
- Sponsors Janssen-Cilag
- 15 Jun 2012 Actual patient number 52 added as reported by ClinicalTrials.gov.
- 18 May 2012 Actual end date Apr 2012 added as reported by ClinicalTrials.gov.
- 18 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.